Latest filing published 31 Dec 2012 for RAMBUS INC.
No signal scores available.
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Abraham D. Sofaer is a declared insider at 3 companies; the most frequent names are Gen Probe Inc, Rambus Inc and Neurobiological Technologies Inc /CA/. The record holds 78 filings, for trades running from 30 June 2005 to 31 December 2012.
Both buying and selling appear: 7 purchases worth €158k, against 1 sale worth €661k. The net balance comes to €503k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 59 share grants and 5 option exercises. Since January 2012: 1 purchase and no sales on the market.
A typical purchase (the median) is worth €6,695. Looking at 6 purchases old enough to measure, the stock rose over the following 90 days in 17% of cases; the median change was -9.5%. This is a record of the past, not a forecast.
On 31 December 2012 came the latest disclosure, a share grant in Rambus Inc. The latest purchase dates back some time: it was published 5,281 days ago, on 9 May 2012. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 72 declarations